CLINICAL STUDY: CARDIAC ELECTROPHYSIOLOGY
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome
Wataru Shimizu, MD, PhD*,*,
Takashi Noda, MD*,
Hiroshi Takaki, MD ,
Takashi Kurita, MD, PhD*,
Noritoshi Nagaya, MD, PhD*,
Kazuhiro Satomi, MD*,
Kazuhiro Suyama, MD, PhD*,
Naohiko Aihara, MD*,
Shiro Kamakura, MD, PhD*,
Kenji Sunagawa, MD, PhD,
Shigeyuki Echigo, MD ,
Kazufumi Nakamura, MD, PhD ,
Tohru Ohe, MD, PhD, FACC,
Jeffrey A. Towbin, MD||,
Carlo Napolitano, MD, PhD¶ and
Silvia G. Priori, MD, PhD¶
* Division of Cardiology, Department of Internal Medicine, Suita, Japan
Department of Cardiovascular DynamicsSuita, Japan
Department of Pediatrics, National Cardiovascular Center, Suita, Japan
Department of Cardiovascular Medicine, Okayama University Graduate School of Medical and Dentistry, Okayama, Japan
|| Department of Pediatrics (Cardiology), Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
¶ Molecular Cardiology, Salvatore Maugeri Foundation, IRCCS, Pavia, Italy
Manuscript received August 19, 2002;
revised manuscript received October 14, 2002,
accepted October 31, 2002.
* Reprint requests and correspondence: Dr. Wataru Shimizu, Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan.
wshimizu{at}hsp.ncvc.go.jp
OBJECTIVES: This study was designed to test the hypothesis that epinephrine infusion may be a provocative test able to unmask nonpenetrant KCNQ1 mutation carriers.
BACKGROUND: The LQT1 form of congenital long QT syndrome is associated with high vulnerability to sympathetic stimulation and appears with incomplete penetrance.
METHODS: The 12-lead electrocardiographic parameters before and after epinephrine infusion were compared among 19 mutation carriers with a baseline corrected QT interval (QTc) of  460 ms (Group I), 15 mutation carriers with a QTc of <460 ms (Group II), 12 nonmutation carriers (Group III), and 15 controls (Group IV).
RESULTS: The mean corrected Q-Tend (QTce), Q-Tpeak (QTcp), and Tpeak-end (Tcp-e) intervals among 12-leads before epinephrine were significantly larger in Group I than in the other three groups. Epinephrine (0.1 µg/kg/min) increased significantly the mean QTce, QTcp, Tcp-e, and the dispersion of QTcp in Groups I and II, but not in Groups III and IV. The sensitivity and specificity of QTce measurements to identify mutation carriers were 59% (20/34) and 100% (27/27), respectively, before epinephrine, and the sensitivity was substantially improved to 91% (31/34) without the expense of specificity (100%, 27/27) after epinephrine. The mean QTce, QTcp, and Tcp-e before and after epinephrine were significantly larger in 15 symptomatic than in 19 asymptomatic mutation carriers in Groups I and II, and the prolongation of the mean QTce with epinephrine was significantly larger in symptomatic patients.
CONCLUSIONS: Epinephrine challenge is a powerful test to establish electrocardiographic diagnosis in silent LQT1 mutation carriers, thus allowing implementation of prophylactic measures aimed at reducing sudden cardiac death.
|
Abbreviations and Acronyms
| | APD | | action potential duration | | ECG | | electrocardiogram | | IKs | | slow component of the delayed rectifier potassium current | | INa | | sodium current | | INa-Ca | | Na+/Ca2+ exchange current | | LQTS | | long QT syndrome | | QTc | | corrected QT interval | | QTce | | corrected Q-Tend interval | | QTcp | | corrected Q-Tpeak interval | | Tcp-e | | corrected interval between Tpeak and Tend | | TdP | | torsade de pointes |
|
This article has been cited by other articles:
|
|
|
|
 
R. C. Ahrens-Nicklas, C. E. Clancy, and D. J. Christini
Re-evaluating the efficacy of {beta}-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling
Cardiovasc Res,
June 1, 2009;
82(3):
439 - 447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ruan, N. Liu, C. Napolitano, and S. G. Priori
Therapeutic Strategies for Long-QT Syndrome: Does the Molecular Substrate Matter?
Circ Arrhythmia Electrophysiol,
October 1, 2008;
1(4):
290 - 297.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Goldenberg and A. J. Moss
Long QT syndrome.
J. Am. Coll. Cardiol.,
June 17, 2008;
51(24):
2291 - 2300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Roden
Long-QT Syndrome
N. Engl. J. Med.,
January 10, 2008;
358(2):
169 - 176.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Yada, M. Murata, K. Shimoda, S. Yuasa, H. Kawaguchi, M. Ieda, T. Adachi, M. Murata, S. Ogawa, and K. Fukuda
Dominant Negative Suppression of Rad Leads to QT Prolongation and Causes Ventricular Arrhythmias via Modulation of L-type Ca2+ Channels in the Heart
Circ. Res.,
July 6, 2007;
101(1):
69 - 77.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Stengl, C. Ramakers, D. W. Donker, A. Nabar, A. V. Rybin, R. L.H.M.G. Spatjens, T. van der Nagel, W. K.W.H. Wodzig, K. R. Sipido, G. Antoons, et al.
Temporal patterns of electrical remodeling in canine ventricular hypertrophy: Focus on IKs downregulation and blunted {beta}-adrenergic activation
Cardiovasc Res,
October 1, 2006;
72(1):
90 - 100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ballo, D. Bernabo, and S. A. Faraguti
Abnormal QT responses to adenosine in subjects with long-QT syndrome
Eur. Heart J.,
July 2, 2006;
27(14):
1759 - 1760.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Vyas, J. Hejlik, and M. J. Ackerman
Epinephrine QT Stress Testing in the Evaluation of Congenital Long-QT Syndrome: Diagnostic Accuracy of the Paradoxical QT Response
Circulation,
March 21, 2006;
113(11):
1385 - 1392.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Viskin, R. Rosso, O. Rogowski, B. Belhassen, A. Levitas, A. Wagshal, A. Katz, D. Fourey, D. Zeltser, A. Oliva, et al.
Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome
Eur. Heart J.,
February 2, 2006;
27(4):
469 - 475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Krahn, M. Gollob, R. Yee, L. J. Gula, A. C. Skanes, B. D. Walker, and G. J. Klein
Diagnosis of Unexplained Cardiac Arrest: Role of Adrenaline and Procainamide Infusion
Circulation,
October 11, 2005;
112(15):
2228 - 2234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Shimizu
The long QT syndrome: Therapeutic implications of a genetic diagnosis
Cardiovasc Res,
August 15, 2005;
67(3):
347 - 356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. F. McBride and C. M. White
Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET
J. Clin. Pharmacol.,
January 1, 2005;
45(1):
6 - 24.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Choi, L. J. Kopplin, D. J. Tester, M. L. Will, C. M. Haglund, and M. J. Ackerman
Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes
Circulation,
October 12, 2004;
110(15):
2119 - 2124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Shimizu, M. Horie, S. Ohno, K. Takenaka, M. Yamaguchi, M. Shimizu, T. Washizuka, Y. Aizawa, K. Nakamura, T. Ohe, et al.
Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: Multicenter study in Japan
J. Am. Coll. Cardiol.,
July 7, 2004;
44(1):
117 - 125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Gouas, C. Bellocq, M. Berthet, F. Potet, S. Demolombe, A. Forhan, R. Lescasse, F. Simon, B. Balkau, I. Denjoy, et al.
New KCNQ1 mutations leading to haploinsufficiency in a general population: Defective trafficking of a KvLQT1 mutant
Cardiovasc Res,
July 1, 2004;
63(1):
60 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Zipes
The year in electrophysiology
J. Am. Coll. Cardiol.,
April 7, 2004;
43(7):
1306 - 1314.
[Full Text]
[PDF]
|
|
|
|
